Frontlight ResearchEarly access
Mesothelioma trials in United States
43 of 52 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleStudy to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- Where
- Arlington, Boston, Chicago, Houston, Minneapolis, New York, San Antonio, San Francisco
- Age
- 18 years and over
- People
- 474 worldwide
- Run by
- Vivace Therapeutics, Inc
See details and how to joinNCT04665206 - Phase 1Taking peopleA Study of VET3-TGI in Patients With Solid Tumors
- Where
- Dallas, Houston, Indianapolis, Los Angeles, Miami, Orange, Pittsburgh, Seattle
- Age
- 18 years and over
- People
- 60
- Run by
- KaliVir Immunotherapeutics
See details and how to joinNCT06444815 - Phase 1Taking peopleA Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Where
- Coral Springs, Duarte, East Brunswick, Fairfax, Fort Worth, Goodyear, Houston, Irving, Jacksonville, Nashville, New York, Omaha, Orlando, Philadelphia, Phoenix, Rochester, Santa Rosa, Seattle, Tampa, Washington D.C., West Valley City, Zion
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07277413 - Phase 1Taking peoplePembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 20
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT03760575 - Phase 1Taking peopleIndividual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 60
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04847063 - Phase 2Taking peopleChemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
- Where
- Appleton, Bemidji, Bismarck, Chicago, Columbus, Conroe, Coon Rapids, Danville, Eau Claire, Edina, Effingham, Fargo, Fridley, Houston, League City, Lexington, Marshfield, Mattoon, Minneapolis, Minocqua, Oklahoma City, Phoenix, Pittsburgh, Rice Lake, Rochester, Saint Louis Park, Saint Paul, Sioux Falls, Stevens Point, Sugar Land, Urbana, Weston, Willmar, Worthington
- Age
- 18 years and over
- People
- 66
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05001880 - Phase 1Taking peopleAnti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 120
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06885697 - Phase 1/2Taking peopleA 2-part Phase 1/2 Open-label Trial on ODM-212
- Where
- Fairfax, Fort Worth, Irving, Los Angeles, Orange
- Age
- 18 years and over
- People
- 229 worldwide
- Run by
- Orion Corporation, Orion Pharma
See details and how to joinNCT07563738 - Phase 1/2Taking peopleVMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Where
- Albuquerque, Englewood, Florham Park, Fort Lauderdale, Hartford, Houston, Morristown, New York, Pembroke Pines, Santa Rosa, Washington D.C., York
- Age
- 18 years to 80 years
- People
- 242 worldwide
- Run by
- VM Oncology, LLC
See details and how to joinNCT03556228 - Phase 1/2Taking peopleRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Where
- Abilene, Augusta, Austin, Boston, Camden, Columbus, Dallas, Detroit, Doylestown, Eugene, Everett, Fairfax, Fort Myers, Fort Worth, Grand Rapids, Los Angeles, Maplewood, Nashville, Norfolk, Oklahoma City, Phoenix, Pittsburgh, Portland, Providence, Rockville, San Diego, Santa Barbara, Santa Rosa, St. Petersburg, Tucson, Tyler, West Palm Beach, West Valley City, Westwood, Woodland
- Age
- 18 years and over
- People
- 952 worldwide
- Run by
- Genmab
See details and how to joinNCT05579366 - Phase 1Taking peopleSW-682 in Advanced Solid Tumors
- Where
- Cleveland, Dallas, Houston, Los Angeles, Portland, Sacramento, Santa Monica, Scottsdale
- Age
- 18 years and over
- People
- 186
- Run by
- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
See details and how to joinNCT06251310 - Phase 2Taking people18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06503146 - Phase 1/2Taking peopleLead-212 PSV359 Therapy for Patients With Solid Tumors
- Where
- Cleveland, Columbus, Dallas, Houston, Kansas City, Lexington, Los Angeles, Madison, Miami, New York, Omaha, Pittsburgh, Rochester, St Louis
- Age
- 18 years to 90 years
- People
- 112
- Run by
- Perspective Therapeutics
See details and how to joinNCT06710756 - Phase 1Taking peopleA Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Where
- Houston, San Antonio, Scottsdale
- Age
- 18 years and over
- People
- 30
- Run by
- SHY Therapeutics
See details and how to joinNCT07705334 - Phase 2Taking peopleDecitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 15
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05960773 - Phase 1/2Taking peopleDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Where
- Boston, Denver, Houston, Miami, Nashville, San Antonio
- Age
- 18 years and over
- People
- 330
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT06239194 - Phase 1Taking peopleA Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 32
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06623396 - Phase 1/2Taking peopleNeoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
- Where
- Durham, Houston
- Age
- 18 years and over
- People
- 52
- Run by
- Baylor College of Medicine
See details and how to joinNCT05932199 - No phaseTaking peopleUsing E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 30 years to 85 years
- People
- 20
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06037941 - Phase 2Taking peopleA Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
- Where
- Ann Arbor, Basking Ridge, Chicago, Commack, Harrison, Middletown, Montvale, New Brunswick, New York, Omaha, Pittsburgh, St Louis, Uniondale
- Age
- 18 years and over
- People
- 64
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06057935 - Phase 1/2Taking peopleStudy of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
- Where
- Austin, Chicago, Cleveland, Denver, Nashville, Philadelphia
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- InSilico Medicine Hong Kong Limited
See details and how to joinNCT06566079 - Phase 1Taking peopleA Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 60
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07532902 - Phase 1/2Taking peopleTT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
- Where
- Houston, Los Angeles
- Age
- 18 years and over
- People
- 35
- Run by
- Portage Biotech
See details and how to joinNCT04969315 - Phase 2Taking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Baltimore, Columbus, Los Angeles, New York, Philadelphia, Stony Brook
- Age
- 18 years to 64 years
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - Phase 1/2Taking peopleSafety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Where
- Boston, Chicago, Detroit, Fairfax, Grand Junction, Houston, Lake Mary, Miami, Nashville, New York, Palo Alto, Salt Lake City, Urbana, Zion
- Age
- 18 years and over
- People
- 225 worldwide
- Run by
- Tango Therapeutics, Inc.
See details and how to joinNCT05732831